Company registration number 08152421 (England and Wales)
I.C ENDOCRINE SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
I.C ENDOCRINE SERVICES LIMITED
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 1 -
2024
2023
£
£
£
£
Fixed assets
16,022
1,330
Current assets
14,063
63,177
Creditors: amounts falling due within one year
(4,382)
(19,040)
Net current assets
9,681
44,137
Total assets less current liabilities
25,703
45,467
Net assets
25,703
45,467
Capital and reserves
25,703
45,467
Notes to the financial statements
1
Directors' benefits: advances, credit and guarantees

 

 

 

At 1 April 2023

 

Advances to director

 

Repayments by director

 

At 31 March 2024

£

£

£

£

Loan account

(3,252)

 

9,950

 

(624)

 

6,074

 

 

 

 

 

 

 

 

 

2
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2024
2023
Number
Number
Employees
2
2

I.C Endocrine Services Limited is a private company limited by shares incorporated in England and Wales. The registered office is Carnac Place, Cams Hall Estate, Fareham, Hampshire, United Kingdom, PO16 8UY.

For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

I.C ENDOCRINE SERVICES LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2024
31 March 2024
- 2 -

These financial statements for the period ended 31 March 2024 are the first financial statements of I.C Endocrine Services Limited has prepared in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and the provisions applicable to companies subject to the small companies regime. The company previously prepared its financial statements in accordance with FRS102 Section 1A.

As part of the transition to FRS105, provisions for liabilities of £252 that were previously recognised in relation to deferred tax under FRS102 Section 1A have been reversed as FRS105 prohibits the recognition of deferred tax. As a result of the transition, there is an impact on total equity and profit and loss of £252.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 29 November 2024 and are signed on its behalf by:
Dr. I Cranston
Director
Company registration number 08152421 (England and Wales)
2024-03-312023-04-01falseCCH SoftwareCCH Accounts Production 2024.210No description of principal activityDr I CranstonMrs T A Cranstonfalsefalse081524212023-04-012024-03-31081524212024-03-31081524212023-03-3108152421core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3108152421core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-31081524212022-04-012023-03-3108152421bus:Director12023-04-012024-03-3108152421bus:PrivateLimitedCompanyLtd2023-04-012024-03-3108152421bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-3108152421bus:Micro-entities2023-04-012024-03-3108152421bus:AuditExemptWithAccountantsReport2023-04-012024-03-3108152421bus:Director22023-04-012024-03-3108152421bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP